Riskpilot← Back to searchSign inGet full accessNordic Lab AB
ABActiveOrg 5591214530Polygonvägen 5Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20171 employees
Revenue 2024
SEK 4M
-1% vs 2023
EBITDA margin
3.9%
+552% vs 2023
Equity ratio
47.7%
Financial strength
Net profit 2024
SEK 116K
+8% vs 2023
| Revenue | SEK 4M | -1% |
| EBITDA | SEK 155K | +552% |
| Net profit | SEK 116K | +8% |
| Total assets | SEK 1,7M | -34% |
| Equity | SEK 799K | +17% |
| Employees | 1 | — |
Legal name
Nordic Lab AB
Org number
5591214530
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14 augusti 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall sälja medicinsk utrustning, hälsokostprodukter och därmed förenlig verksamhet.
Address
Polygonvägen 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 965 | 1 340 | 3 969 | 4 058 | 4 010 |
| Staff expenses | — | — | −422 | −473 | −391 |
| EBITDA | 1 | 190 | 198 | 24 | 155 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 1 | 190 | 198 | 24 | 155 |
| Net financials | −1 | — | −0 | −1 | −7 |
| Profit before tax | 68 | 145 | 153 | 143 | 148 |
| Tax | −15 | −30 | −34 | −35 | −32 |
| Net profit | 53 | 115 | 119 | 108 | 116 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 593 | 696 | 923 | 2 519 | 1 675 |
| Equity | 342 | 457 | 576 | 684 | 799 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 221 | 164 | 228 | 1 836 | 876 |
| Total debt | 221 | 164 | 228 | 1 836 | 876 |
EBITDA margin
3.9%
This company
15.8%
Market median
-75% vs market
20202024
Equity ratio
47.7%
This company
38.2%
Market median
+25% vs market
20202024
Return on equity
14.5%
This company
18.4%
Market median
+21% vs market
20202024
Net profit margin
2.9%
This company
8.1%
Market median
-64% vs market
20202024
Asset turnover
2.39×
This company
1.12×
Market median
+113% vs market
20202024
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2021 | |
| Board of Directors | 2025 | |
| Chairman | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nordic Lab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Ivar Broberg | Board of Directors | 0 companies |
| Keiran Marcus Widell | Deputy Board Member | 0 companies |
| Hans Stefan Hultin | Board of Directors | 0 companies |
| Kicki Maria Johansson | Board of Directors | 0 companies |
| Frédéric Sebastian Nikodemus Widell | Chairman | 0 companies |